A carregar...
Monoclonal Antibody Combinations that Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin Drugs
Monoclonal antibodies (MAbs) are among the fastest-growing therapeutics and are being developed for a broad range of indications, including the neutralization of toxins, bacteria and viruses. Nevertheless, MAbs potency is still relatively low when compared to conventional polyclonal Ab preparations....
Na minha lista:
| Publicado no: | Toxins (Basel) |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4488679/ https://ncbi.nlm.nih.gov/pubmed/26035486 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/toxins7061854 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|